These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals. Clarke SE, Lazarus CR, Maisey MN. Henry Ford Hosp Med J; 1987 Feb; 35(2-3):124-6. PubMed ID: 2826368 [No Abstract] [Full Text] [Related]
3. [Scintigraphy of medullary carcinoma of the thyroid by new radiopharmaceuticals]. Tada J, Konishi J, Torizuka K, Makimoto K, Miyauchi A. Rinsho Hoshasen; 1984 Sep; 29(9):1043-4. PubMed ID: 6096600 [No Abstract] [Full Text] [Related]
4. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma. Hilditch TE, Connell JM, Elliot AT, Murray T, Reed NS. J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086 [Abstract] [Full Text] [Related]
12. The role of imaging tests in the diagnosis of thyroid carcinoma. Shulkin BL, Shapiro B. Endocrinol Metab Clin North Am; 1990 Sep; 19(3):523-43. PubMed ID: 2175703 [Abstract] [Full Text] [Related]
13. Positive scintigraphy of medullary thyroid cancer using 201Tl and alkalized 99mTc-DMSA. Holub V, Nĕmec J, Neradilová M, Benová M, Blazek T, Dusek M. Radiobiol Radiother (Berl); 1987 Sep; 28(5):640-2. PubMed ID: 2831559 [No Abstract] [Full Text] [Related]
17. A false positive I-131 MIBG due to dilated renal pelvis: a case report. Bahar RH, Mahmoud S, Ibrahim A, al-Gazzar AH. Clin Nucl Med; 1988 Dec; 13(12):900-2. PubMed ID: 2854506 [Abstract] [Full Text] [Related]